Why Accendra Health, Inc.’s (ACH) Stock Is Down 8.98%
As of Friday, July 31, Accendra Health, Inc.’s ACH share price has dipped by 8.98%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Commentary & Analysis
Why Accendra Health, Inc.’s (ACH) Stock Is Down 5.56%
As of Friday, July 17, Accendra Health, Inc.’s ACH share price has dipped by 5.56%, which has investors questioning if this is right time to buy.Michael Rose
Why Accendra Health, Inc.’s (ACH) Stock Is Up 6.71%
As of Wednesday, June 24, Accendra Health, Inc.’s ACH share price has surged by 6.71%, which has investors questioning if this is right time to sell.Michael Rose
Why Accendra Health, Inc.’s (ACH) Stock Is Up 6.33%
As of Thursday, June 18, Accendra Health, Inc.’s ACH share price has surged by 6.33%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Accendra Health, Inc.’s (ACH) Stock Is Down 7.21%
As of Monday, June 15, Accendra Health, Inc.’s ACH share price has dipped by 7.21%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Financial Summary
| Share Statistics | ACH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $255.8 | $1,875.0 | 30% |
|
| Shares Out (Mil) | 76.4 | 77.1 | 57% |
|
| Institutional Ownership | 87.8% | 88.9% | 56% |
|
| Float (Mil) | 56.2 | 50.3 | 50% |
|
| Beta | 1.70 | 0.86 | 87% |
|
| Avg Daily Volume (000s) | 390 | 466 | 55% |
|
| Price Change (52-week) |
(55.2%) | 78.5% | 14% |
|
| Growth | ACH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (20.1%) | 10.9% | 2% |
|
| Net Income (5yr) | (107.9%) | (1.1%) | 1% |
|
| EPS (5yr) | (100.5%) | 3.0% | 1 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | 30.8% | (18.2%) | 86% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | ($0.088) | $0.383 | $0.692 | |
| Month Ago EPS | ($0.085) | $0.419 | $0.688 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $0.120 | $0.669 | $1.040 | |
| Year/Year Chg | 3.5% | (128.6%) | (168.1%) | |
| Financials | ACH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,716 | $1,464 | 65% |
|
| Net Income (TTM) (Mil) | ($1,082) | $15 | 1% |
|
| EPS (TTM) | ($14.111) | $0.300 | 3% |
|
| Operating Cash Flow (TTM) (Mil) | ($117) | $138 | 5% |
|
| Net Cash Flow (TTM) (Mil) | $277 | $7 | 87% |
|
| Long-Term Debt (Q1) (Mil) | $1,589 | $323 | 71% |
|
| Enterprise Value (Q1) (Mil) | $2,130 | $2,130 | 50% |
|
| Valuation | ACH | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.90 | na |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | ACH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 46.0% | 27.6% | 58% |
|
| Net Margin | (39.8%) | 1.1% | 13% |
|
| ROA | (29.8%) | 1.8% | 17% |
|
| ROE | na | 6.9% | na |
|
| Liabilities to Assets | 119.2% | 60.0% | 96% |
|
| F-Score | 2 | 5 | na |
|
Accendra Health, Inc. did not pass any screens on 7/30/2026.
